{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:09:43Z","timestamp":1779178183682,"version":"3.51.4"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C355\/A26819"],"award-info":[{"award-number":["C355\/A26819"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The emergence of large-scale omics data and foundational models has renewed efforts in the field of cancer drug response prediction (DRP). Despite recent progress, challenges such as limited tumor heterogeneity in standard cell lines and inconsistencies in experimental protocols across studies persist. However, these challenges also open significant opportunities for innovation. The complex nature of drug responses, influenced by variations in new patients and new drugs, presents a critical area for advancing validation approaches that traditional machine learning approaches often overlook. This review provides a comprehensive overview of the current state of DRP using advanced machine-learning models, discussing data sources, model designs, and evaluation methods. We introduce a unified framework for testing these models with a focus on clinically relevant metrics. By evaluating a range of foundational and deep-learning models within this framework, we identify performance gaps and propose concrete strategies to advance these computational models for reliable use in personalized cancer treatment, thereby unlocking their full clinical potential.<\/jats:p>","DOI":"10.1093\/bib\/bbag225","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:43:24Z","timestamp":1776944604000},"source":"Crossref","is-referenced-by-count":0,"title":["Foundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-7962","authenticated-orcid":false,"given":"Katyna","family":"Sada Del Real","sequence":"first","affiliation":[{"name":"Departamento de Ingenier\u00eda Biom\u00e9dica y Ciencias , , Paseo de Manuel Lardiz\u00e1bal 13, 20018 San Sebasti\u00e1n, Gipuzkoa ,","place":["Spain"]},{"name":"TECNUN, Universidad de Navarra , , Paseo de Manuel Lardiz\u00e1bal 13, 20018 San Sebasti\u00e1n, Gipuzkoa ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay S","family":"Swamy","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Columbia University , 622 West 168th Street, Washington Heights, New York, NY 10032 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4146-5780","authenticated-orcid":false,"given":"Josefina","family":"Arcagni","sequence":"additional","affiliation":[{"name":"Departamento de Ingenier\u00eda Biom\u00e9dica y Ciencias , , Paseo de Manuel Lardiz\u00e1bal 13, 20018 San Sebasti\u00e1n, Gipuzkoa ,","place":["Spain"]},{"name":"TECNUN, Universidad de Navarra , , Paseo de Manuel Lardiz\u00e1bal 13, 20018 San Sebasti\u00e1n, Gipuzkoa ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Wang","sequence":"additional","affiliation":[{"name":"Google DeepMind , 1600 Amphitheatre Parkway, North Bayshore, Mountain View, CA 94043 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7946-9255","authenticated-orcid":false,"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[{"name":"Google DeepMind , 1600 Amphitheatre Parkway, North Bayshore, Mountain View, CA 94043 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-2450","authenticated-orcid":false,"given":"Angel","family":"Rubio","sequence":"additional","affiliation":[{"name":"Departamento de Ingenier\u00eda Biom\u00e9dica y Ciencias , , Paseo de Manuel Lardiz\u00e1bal 13, 20018 San Sebasti\u00e1n, Gipuzkoa ,","place":["Spain"]},{"name":"TECNUN, Universidad de Navarra , , Paseo de Manuel Lardiz\u00e1bal 13, 20018 San Sebasti\u00e1n, Gipuzkoa ,","place":["Spain"]},{"name":"Instituto de Ciencia de Datos e Inteligencia Artificial (DATAI), Universidad de Navarra , 31080 Pamplona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2026051903554680200_ref1","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1007\/S10462-022-10306-1\/FIGURES\/11","article-title":"Deep learning in drug discovery: an integrative review and future challenges","volume":"56","author":"Askr","year":"2023","journal-title":"Artif Intell Rev"},{"key":"2026051903554680200_ref2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1158\/1535-7163.MCT-06-0650\/357219\/P\/TRANSCRIPT-AND-PROTEIN-EXPRESSION-PROFILES-OF-THE","article-title":"Transcript and protein expression profiles of the NCI-60 cancer cell panel: An integromic microarray study","volume":"6","author":"Shankavaram","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"2026051903554680200_ref3","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","article-title":"CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set NIH public access","volume":"72","author":"Reinhold WC","year":"2012","journal-title":"Cancer Res"},{"key":"2026051903554680200_ref4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1158\/0008-5472.CAN-16-0655","article-title":"The NCI-60 methylome and its integration into CellMiner","volume":"77","author":"Reinhold","year":"2016","journal-title":"Cancer Res"},{"key":"2026051903554680200_ref5","doi-asserted-by":"publisher","first-page":"e92047","DOI":"10.1371\/JOURNAL.PONE.0092047","article-title":"High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner","volume":"9","author":"Varma","year":"2014","journal-title":"PLoS One"},{"key":"2026051903554680200_ref6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"2026051903554680200_ref7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/NATURE11003","article-title":"The cancer cell line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature."},{"key":"2026051903554680200_ref8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/J.CELL.2016.06.017\/ATTACHMENT\/2690C3CA-4270-4D2A-8984-FDDCBFA738C7\/MMC9.PDF","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell."},{"key":"2026051903554680200_ref9","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026051903554680200_ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09940-1","article-title":"Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening","volume":"10","author":"Picco","year":"2019","journal-title":"Nat Commun"},{"key":"2026051903554680200_ref11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cels.2017.11.001","article-title":"The library of integrated network-based cellular signatures NIH program: system-level Cataloging of human cells response to perturbations","volume":"6","author":"Keenan","year":"2018","journal-title":"Cell Systems"},{"key":"2026051903554680200_ref12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41588-018-0209-6","article-title":"Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy","volume":"50","author":"Lee","year":"2018","journal-title":"Nat Genet"},{"key":"2026051903554680200_ref13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1158\/2159-8290.CD-19-1209","article-title":"Characteristics and outcome of AKT1 E17K-mutant breast cancer defined through AACR project GENIE, a Clinicogenomic registry","volume":"10","author":"Smyth","year":"2020","journal-title":"Cancer Discov"},{"key":"2026051903554680200_ref14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anticancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat Cancer"},{"key":"2026051903554680200_ref15","doi-asserted-by":"publisher","first-page":"i911","DOI":"10.1093\/bioinformatics\/btaa822","article-title":"DeepCDR: a hybrid graph convolutional network for predicting cancer drug response","volume":"36","author":"Liu","year":"2020","journal-title":"Bioinformatics"},{"key":"2026051903554680200_ref16","doi-asserted-by":"publisher","first-page":"i501","DOI":"10.1093\/bioinformatics\/btz318","article-title":"MOLI: multi-omics late integration with deep neural networks for drug response prediction","volume":"35","author":"Sharifi-Noghabi","year":"2019","journal-title":"Bioinformatics"},{"key":"2026051903554680200_ref17","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1021\/ACS.MOLPHARMACEUT.9B00520\/SUPPL_FILE\/MP9B00520_SI_001.PDF","article-title":"Toward explainable anticancer compound sensitivity prediction via multimodal attention-based convolutional encoders","volume":"16","author":"Manica","year":"2019","journal-title":"Mol Pharm"},{"key":"2026051903554680200_ref18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41592-024-02305-7","article-title":"Large-scale foundation model on single-cell transcriptomics","volume":"21","author":"Hao","year":"2024","journal-title":"Nat Methods"},{"key":"2026051903554680200_ref19","article-title":"TxGemma: Efficient and Agentic LLMs for Therapeutics","author":"Wang","year":"2025"},{"key":"2026051903554680200_ref20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/S12599-024-00851-0\/FIGURES\/2","article-title":"Foundation models: a new paradigm for artificial intelligence. Business and information","volume":"66","author":"Schneider","year":"2024","journal-title":"Syst Eng"},{"key":"2026051903554680200_ref21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ng.3756","article-title":"Precision oncology for acute myeloid leukemia using a knowledge bank approach","volume":"49","author":"Gerstung","year":"2017","journal-title":"Nat Genet"},{"key":"2026051903554680200_ref22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/S00439-019-01970-5","article-title":"Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives","volume":"138","author":"Xu","year":"2019","journal-title":"Hum Genet"},{"key":"2026051903554680200_ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbac605","article-title":"A systematic assessment of deep learning methods for drug response prediction: from in vitro to clinical applications","volume":"24","author":"Shen","year":"2023","journal-title":"Brief Bioinform"},{"key":"2026051903554680200_ref24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/J.GPB.2023.01.006","article-title":"Preclinical-to-clinical anti-cancer drug response prediction and biomarker identification using TINDL","volume":"21","author":"Hostallero","year":"2023","journal-title":"Genom Proteom Bioinform"},{"key":"2026051903554680200_ref25","doi-asserted-by":"publisher","first-page":"1086097","DOI":"10.3389\/FMED.2023.1086097\/BIBTEX","article-title":"Deep learning methods for drug response prediction in cancer: predominant and emerging trends","volume":"10","author":"Partin","year":"2023","journal-title":"Front Med"},{"key":"2026051903554680200_ref26","doi-asserted-by":"publisher","first-page":"641980","DOI":"10.3389\/fonc.2021.641980","article-title":"Patient-derived cancer organoids as predictors of treatment response","volume":"11","author":"Verduin","journal-title":"Front Oncol"},{"key":"2026051903554680200_ref27","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0959-8049(22)00825-5","article-title":"Impact of orthotopic versus subcutaneous implantation on patient-derived xenograft transcriptomic profile","volume":"174","author":"Sheng","year":"2022","journal-title":"Eur J Cancer"},{"key":"2026051903554680200_ref28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat Rev Genet"},{"key":"2026051903554680200_ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001624","article-title":"A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models","volume":"20","author":"Singh","year":"2022","journal-title":"PLoS Biol"},{"key":"2026051903554680200_ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02526-y","article-title":"Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response","volume":"4","author":"Petreus","year":"2021","journal-title":"Commun Biol"},{"key":"2026051903554680200_ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-024-00583-0","article-title":"Overcoming limitations in current measures of drug response may enable AI-driven precision oncology","volume":"8","author":"Ovchinnikova","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"2026051903554680200_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104767","article-title":"Discovering the mechanism of action of drugs with a sparse explainable network","volume":"95","author":"Sada","year":"2023","journal-title":"eBioMedicine"},{"key":"2026051903554680200_ref33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4627","article-title":"Using deep learning to model the hierarchical structure and function of a cell","volume":"15","author":"Ma","year":"2018","journal-title":"Nat Methods"},{"key":"2026051903554680200_ref34","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae449","article-title":"Designing interpretable deep learning applications for functional genomics: a quantitative analysis","volume":"25","author":"Van Hilten","year":"2024","journal-title":"Brief Bioinform"},{"key":"2026051903554680200_ref35","doi-asserted-by":"publisher","article-title":"Deep learning methods for drug response prediction in cancer: predominant and emerging trends","volume-title":"Frontiers in Medicine","DOI":"10.3389\/fmed.2023.1086097"},{"key":"2026051903554680200_ref36","doi-asserted-by":"publisher","first-page":"1036963","DOI":"10.3389\/FBINF.2022.1036963\/FULL","article-title":"Opportunities and challenges in interpretable deep learning for drug sensitivity prediction of cancer cells. Frontiers","volume":"2","author":"Samal","year":"2022","journal-title":"Bioinformatics."},{"key":"2026051903554680200_ref37","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac100","article-title":"DeepTTA: a transformer-based model for predicting cancer drug response","volume":"23","author":"Jiang","year":"2022","journal-title":"Brief Bioinform"},{"key":"2026051903554680200_ref38","doi-asserted-by":"publisher","DOI":"10.1093\/bioadv\/vbae010","article-title":"MMDRP: drug response prediction and biomarker discovery using multi-modal deep learning","volume":"4","author":"Taj","year":"2024","journal-title":"Bioinform Adv"},{"key":"2026051903554680200_ref39","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2026051903554680200_ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbab393","article-title":"Representation of molecules for drug response prediction","volume":"23","author":"An","year":"2022","journal-title":"Brief Bioinform"},{"key":"2026051903554680200_ref41","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","article-title":"Predicting drug response and synergy using a deep learning model of human cancer cells","volume":"38","author":"Kuenzi","year":"2020","journal-title":"Cancer Cell"},{"key":"2026051903554680200_ref42","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad390","article-title":"Interpretable deep learning architectures for improving drug response prediction performance: myth or reality?","volume":"39","author":"Li","year":"2023","journal-title":"Bioinformatics"},{"key":"2026051903554680200_ref43","doi-asserted-by":"publisher","first-page":"D1096","DOI":"10.1093\/nar\/gks966","article-title":"BioLiP: a semi-manually curated database for biologically relevant ligand\u2013protein interactions","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026051903554680200_ref44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11735","article-title":"Addendum: the cancer cell line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2026051903554680200_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2024.E27190","article-title":"Uncovering the subtype-specific disease module and the development of drug response prediction models for glioma","volume":"10","author":"Munquad","year":"2024","journal-title":"Heliyon."},{"key":"2026051903554680200_ref46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/J.YMETH.2023.11.018","article-title":"Improving anti-cancer drug response prediction using multi-task learning on graph convolutional networks","volume":"222","author":"Liu","year":"2024","journal-title":"Methods"},{"key":"2026051903554680200_ref47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s43018-024-00740-1","article-title":"A deep learning model of tumor cell architecture elucidates response and resistance to CDK4\/6 inhibitors","volume":"5","author":"Park","year":"2024","journal-title":"Nature Cancer"},{"key":"2026051903554680200_ref48","article-title":"Attention is all you need (transformer architecture)","author":"Vaswani","year":"2023"},{"key":"2026051903554680200_ref49","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.1093\/nar\/gky889","article-title":"Multi-omic and multi-view clustering algorithms: review and cancer benchmark","volume":"46","author":"Rappoport","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026051903554680200_ref50","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/bioinformatics\/btw344","article-title":"Evaluating the molecule-based prediction of clinical drug responses in cancer","volume":"32","author":"Ding","year":"2016","journal-title":"Bioinformatics"},{"key":"2026051903554680200_ref51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27214-6","article-title":"Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"key":"2026051903554680200_ref52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061318","article-title":"Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties","volume":"8","author":"Menden","year":"2013","journal-title":"PLoS One"},{"key":"2026051903554680200_ref53","doi-asserted-by":"publisher","DOI":"10.1093\/NARGAB\/LQAB097","article-title":"ParsVNN: parsimony visible neural networks for uncovering cancer-specific and drug-sensitive genes and pathways","volume":"3","author":"Huang","year":"2021","journal-title":"NAR Genom Bioinform"},{"key":"2026051903554680200_ref54","doi-asserted-by":"publisher","first-page":"639349","DOI":"10.3389\/FBINF.2021.639349\/FULL","article-title":"Predicting anticancer drug response with deep learning constrained by Signaling pathways. Frontiers","volume":"1","author":"Zhang","year":"2021","journal-title":"Bioinformatics"},{"key":"2026051903554680200_ref55","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1021\/ACS.JCIM.0C00331\/SUPPL_FILE\/CI0C00331_SI_001.PDF","article-title":"Pathway-guided deep neural network toward interpretable and predictive modeling of drug sensitivity","volume":"60","author":"Deng","year":"2020","journal-title":"J Chem Inf Model"},{"key":"2026051903554680200_ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12859-024-05723-8\/TABLES\/3","article-title":"DeepAEG: a model for predicting cancer drug response based on data enhancement and edge-collaborative update strategies","volume":"25","author":"Lao","year":"2024","journal-title":"BMC Bioinformatics"},{"key":"2026051903554680200_ref57","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac501","article-title":"GADRP: graph convolutional networks and autoencoders for cancer drug response prediction","volume":"24","author":"Wang","year":"2023","journal-title":"Brief Bioinform"},{"key":"2026051903554680200_ref58","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12916-022-02549-0","article-title":"NeRD: a multichannel neural network to predict cellular response of drugs by integrating multidimensional data","volume":"20","author":"Cheng","year":"2022","journal-title":"BMC Med"},{"key":"2026051903554680200_ref59","doi-asserted-by":"publisher","first-page":"102485","DOI":"10.1016\/j.inffus.2024.102485","article-title":"A hierarchical attention network integrating multi-scale relationship for drug response prediction","volume":"110","author":"Wang","year":"2024","journal-title":"Inf Fusion"},{"key":"2026051903554680200_ref60","volume-title":"Experiment Tracking with Weights and Biases","author":"Biewald","year":"2020"},{"key":"2026051903554680200_ref61","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1021\/ACS.JCIM.1C00706\/SUPPL_FILE\/CI1C00706_SI_003.XLSX","article-title":"HiDRA: hierarchical network for drug response prediction with attention","volume":"61","author":"Jin","year":"2021","journal-title":"J Chem Inf Model"},{"key":"2026051903554680200_ref62","first-page":"32100","volume-title":"DoRA: Weight-Decomposed Low-Rank Adaptation","author":"Liu","year":"2024"},{"key":"2026051903554680200_ref63","volume-title":"Gemma 3 Technical","author":"Team G","year":"2025"},{"key":"2026051903554680200_ref64","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1158\/2767-9764.CRC-24-0285","article-title":"DeePathNet: a transformer-based deep learning model integrating Multiomic data with cancer pathways. Cancer research","volume":"4","author":"Cai","year":"2024","journal-title":"Communications."},{"key":"2026051903554680200_ref65","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"key":"2026051903554680200_ref66","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov"},{"key":"2026051903554680200_ref67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2026051903554680200_ref68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature17987","article-title":"Reproducible pharmacogenomic profiling of cancer cell line panels","volume":"533","author":"Haverty","year":"2016","journal-title":"Nature"},{"key":"2026051903554680200_ref69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-83090-3","article-title":"Drug discovery and mechanism prediction with explainable graph neural networks","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"2026051903554680200_ref70","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3390\/cancers15102705","article-title":"Hybrid quantum neural network for drug response prediction","volume":"15","author":"Belli","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026051903554680200_ref71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12859-021-04352-9\/TABLES\/4","article-title":"SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures","volume":"22","author":"Zuo","year":"2021","journal-title":"BMC Bioinformatics"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/27\/3\/bbag225\/68332764\/bbag225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/27\/3\/bbag225\/68332764\/bbag225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:55:53Z","timestamp":1779177353000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbag225\/8687196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbag225","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]},"article-number":"bbag225"}}